Reference
Limb M. Excluding NICE from early stages of value based pricing scheme was 'big win for pharma' conference is told. BMJ : 18 Nov 2013. Available from: URL: http://dx.doi.org/10.1136/bmj.f6906
Rights and permissions
About this article
Cite this article
Delays in UK value-based pricing scheme a win for big pharma. PharmacoEcon Outcomes News 692, 10 (2013). https://doi.org/10.1007/s40274-013-0899-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0899-z